Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1503518/000104746912003129/a2208321z10-k.htm
Exhibit 99.1
RADIATION THERAPY SERVICES HOLDINGS, INC.
Contact: Bryan J. Carey Chief Financial Officer (239) 931-7281 BCarey@rtsx.com |
Investors: Amy Glynn / Nick Laudico The Ruth Group 646-536-7023 / 7030 aglynn@theruthgroup.com nlaudico@theruthgroup.com |
RADIATION THERAPY SERVICES REPORTS PRELIMINARY FOURTH QUARTER AND YEAR ENDED 2011 FINANCIAL RESULTS
Fourth Quarter 2011 Highlights:
· Total company pro forma revenues grew by 23. 3% to $171.2 million
· Domestic same practice treatments per day increased 3.0%
· International treatments increased 13.6%
· Pro Forma Adjusted EBITDA of $28.8 million
Full Year 2011 Business Highlights
· Completed strategic acquisitions in Argentina, Redding, CA and Goldsboro, NC, further building market presence
· Obtained CONs in attractive markets of Conway, SC and Asheville, NC
· Increased revolver by $50 million and amended Senior Credit Facility to support continued growth
· Appointed Bryan J. Carey as permanent Chief Financial Officer
· Implemented strategies to partially offset reductions in 2012 reimbursement
· Pro Forma Adjusted EBITDA of $122.8 million
FORT MYERS, FL, March 7, 2012 Radiation Therapy Services Holdings, Inc (the Company), a leading operator of radiation therapy centers, today announced preliminary financial results for the fourth quarter and year ended December 31, 2011.
Dr. Daniel Dosoretz, President and Chief Executive Officer, said, During the fourth quarter, we saw a continued trend of improving volumes, with domestic same practice treatments per day up 3.0%. This increase reflects a continued rebound in services in some of our key markets, such as Florida and Michigan, as well as the impact of our marketing initiatives. The 13.1% increase in same practice RVUs per day also reflects our continuing mix shift towards more clinically appropriate and sophisticated radiation oncology services.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1503518/000104746912003129/a2208321z10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by 21St Century Oncology Holdings, Inc..
21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
21St Century Oncology Holdings, Inc. provided additional information to their SEC Filing as exhibits
Ticker: RTSX
CIK: 1503518
Form Type: 10-K Annual Report
Accession Number: 0001047469-12-003129
Submitted to the SEC: Thu Mar 22 2012 3:23:40 PM EST
Accepted by the SEC: Thu Mar 22 2012
Period: Saturday, December 31, 2011
Industry: Offices And Clinics Of Doctors Of Medicine